Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Antibiotic bead chains

K W Klemm1

  • 1Unfallklinik, Frankfurt am Main, Germany.

Clinical Orthopaedics and Related Research
|October 1, 1993
PubMed
Summary
This summary is machine-generated.

Gentamicin-PMMA chains offer effective local antibiotic delivery for bone infections, achieving high concentrations with minimal systemic toxicity. This method enhances patient comfort and reduces hospitalization for chronic osteomyelitis treatment.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Gentamicin-PMMA chains (Septopal chains) for the local antibiotic treatment of chronic osteomyelitis.

Reconstruction surgery and traumatology·1988
Same author

Treatment of infected pseudarthrosis of the femur and tibia with an interlocking nail.

Clinical orthopaedics and related research·1986
Same author

Interlocking nailing of complex fractures of the femur and tibia.

Clinical orthopaedics and related research·1986
See all related articles

Area of Science:

  • Orthopedics
  • Infectious Diseases
  • Biomaterials

Background:

  • Chronic osteomyelitis and bone infections pose significant treatment challenges.
  • Systemic antibiotic therapy often leads to toxicity and sub-optimal drug concentrations at the infection site.
  • Local antibiotic delivery systems aim to overcome these limitations.

Observation:

  • Gentamicin-polymethylmethacrylate (PMMA) chains provide sustained local release of gentamicin.
  • High gentamicin concentrations are achieved directly at the infection site, exceeding minimal inhibitory concentrations for common pathogens.
  • Serum and urine gentamicin levels remain very low, minimizing the risk of systemic toxicity.

Findings:

  • Radical debridement and removal of infected bone/implants are crucial prior to gentamicin-PMMA chain implantation.

Related Experiment Videos

  • Primary wound closure is essential for maintaining high local antibiotic concentrations.
  • Gentamicin-PMMA chains can be used for temporary or permanent filling of infected bone cavities.

    • Implications:

    • This approach offers significant advantages for treating chronic osteomyelitis, including sequestrating osteomyelitis, infected osteosynthesis, and infected pseudarthrosis.
    • Benefits include enhanced patient comfort via primary wound closure, elimination of prolonged systemic antibiotic use, and avoidance of irrigation-suction-drainage.
    • The method facilitates early ambulation, shortens hospitalization, and reduces overall treatment costs.